SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-14-128101
Filing Date
2014-04-02
Accepted
2014-04-02 16:30:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO.2 d704106dsc13da.htm SC 13D/A 28752
2 EX-9 d704106dex9.htm EX-9 63164
  Complete submission text file 0001193125-14-128101.txt   93414
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Subject) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87630 | Film No.: 14738505
SIC: 2836 Biological Products, (No Diagnostic Substances)